サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：心臓バイオインプラントデバイス市場：規模、世界市場の予測（2023年～2030年）、業界動向、成長、シェア、見通し、インフレの影響、企業の機会分析
市場調査レポート
商品コード
1338995

心臓バイオインプラントデバイス市場：規模、世界市場の予測（2023年～2030年）、業界動向、成長、シェア、見通し、インフレの影響、企業の機会分析

Cardiac Bio Implant Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
出版日: | 発行: Renub Research | ページ情報: 英文 210 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
心臓バイオインプラントデバイス市場：規模、世界市場の予測（2023年～2030年）、業界動向、成長、シェア、見通し、インフレの影響、企業の機会分析
出版日: 2023年08月01日
発行: Renub Research
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心臓バイオインプラントデバイスの市場規模は2030年までに602億米ドルになると予測されています。世界で最も一般的な死亡原因は心血管疾患（CVD）であり、心臓発作や脳卒中のリスクを高める血管の収縮が特徴です。血流の回復には、冠動脈バイパス移植術（CABG）や経皮的冠動脈インターベンション（PCI）などの外科手術が頻繁に行われます。

しかし、それでもなお、患者は、グラフト不全やステント内再狭窄（ISR）などの結果によって、病状が悪化し、死亡率が上昇する危険性があります。研究開発者たちは、このような問題に対処するために、センサーとリアルタイム追跡機能を備えた高度な心血管バイオインプラントを開発しています。ISRや移植片の破損を防ぐために、これらの技術は、兆候が現れる前であっても、病気の症状を早期に発見しようとしています。

世界の心臓バイオインプラントの市場規模は、2022年～2030年にかけて7.13％のCAGRで拡大すると予測されています。

市場拡大の大きな原動力は、関節鏡や理学療法のような代替療法よりも、より優れた成就価格と生体適合性のために望まれているバイオインプラント治療の魅力の高まりです。整形外科疾患や心血管疾患の有病率の改善、高齢者人口の増加、存在の変換、美容外科手術の使用の増加などからなる結果として、市場は成長すると思われます。

米国疾病管理予防センターのデータによると、20歳以上の高齢者2,010万人以上が影響を受けている冠状動脈性心臓疾患は、米国で最も一般的な冠状動脈性心臓疾患です。米国では年間80万5,000人が心臓発作を起こし、40秒に1人が心臓発作を起こすと予測されています。慢性的な状況の増加は、バイオインプラントの需要をさらに増加させると思われます。世界の心臓バイオインプラント市場は、2022年には347億米ドル規模になると予測されています。

当レポートでは、世界の心臓バイオインプラントデバイス市場について調査し、市場の概要とともに、タイプ別、用途別、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

第5章 心臓バイオインプラントデバイス市場

第6章 市場シェア- 心臓バイオインプラントデバイス市場

  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別

第7章 タイプ- 心臓バイオインプラントデバイス市場

  • ペースメーカー
  • ICD（植込み型除細動器）
  • CRT（心臓再同期療法）

第8章 用途- 心臓バイオインプラントデバイス市場

  • 不整脈
  • 心筋虚血
  • 急性心筋梗塞
  • 心不全

第9章 エンドユーザー- 心臓バイオインプラントデバイス市場

  • 病院
  • 外来手術センター
  • 心臓カテーテル検査研究室
  • その他

第10章 国- 心臓バイオインプラントデバイス市場

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
  • その他の地域

第11章 ポーターファイブフォース分析- 心臓バイオインプラントデバイス市場

第12章 SWOT分析- 心臓バイオインプラントデバイス市場

第13章 主要企業の分析

  • F. Hoffman-La Roche
  • Eurofins Scientific
  • Illumina, Inc
  • Natera Inc
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • Agilent Technologies
図表

List of Figures

  • Figure-01: Global - Cardiac Bio Implant Devices Market (Billion US$), 2018 - 2022
  • Figure-02: Global - Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2023 - 2030
  • Figure-03: Type - Pacemaker Market (Billion US$), 2018 - 2022
  • Figure-04: Type - Forecast for Pacemaker Market (Billion US$), 2023 - 2030
  • Figure-05: Type - ICDs (Implantable Cardioverter Defibrillator) Market (Billion US$), 2018 - 2022
  • Figure-06: Type - Forecast for ICDs (Implantable Cardioverter Defibrillator) Market (Billion US$), 2023 - 2030
  • Figure-07: Type - CRT (Cardiac Resynchronization Therapy) Market (Billion US$), 2018 - 2022
  • Figure-08: Type - Forecast for CRT (Cardiac Resynchronization Therapy) Market (Billion US$), 2023 - 2030
  • Figure-09: Application - Arrhythmias Market (Billion US$), 2018 - 2022
  • Figure-10: Application - Forecast for Arrhythmias Market (Billion US$), 2023 - 2030
  • Figure-11: Application - Myocardial Ischemia Market (Billion US$), 2018 - 2022
  • Figure-12: Application - Forecast for Myocardial Ischemia Market (Billion US$), 2023 - 2030
  • Figure-13: Application - Acute Myocardial Infarction Market (Billion US$), 2018 - 2022
  • Figure-14: Application - Forecast for Acute Myocardial Infarction Market (Billion US$), 2023 - 2030
  • Figure-15: Application - Heart Failure Market (Billion US$), 2018 - 2022
  • Figure-16: Application - Forecast for Heart Failure Market (Billion US$), 2023 - 2030
  • Figure-17: End-User - Hospitals Market (Billion US$), 2018 - 2022
  • Figure-18: End-User - Forecast for Hospitals Market (Billion US$), 2023 - 2030
  • Figure-19: End-User - Ambulatory Surgical Centers Market (Billion US$), 2018 - 2022
  • Figure-20: End-User - Forecast for Ambulatory Surgical Centers Market (Billion US$), 2023 - 2030
  • Figure-21: End-User - Cardiac Catheterization Laboratories Market (Billion US$), 2018 - 2022
  • Figure-22: End-User - Forecast for Cardiac Catheterization Laboratories Market (Billion US$), 2023 - 2030
  • Figure-23: End-User - Others Market (Billion US$), 2018 - 2022
  • Figure-24: End-User - Forecast for Others Market (Billion US$), 2023 - 2030
  • Figure-25: United States - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-26: United States - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-27: Canada - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-28: Canada - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-29: France - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-30: France - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-31: Germany - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-32: Germany - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-33: Italy - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-34: Italy - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-35: Spain - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-36: Spain - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-37: United Kingdom - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-38: United Kingdom - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-39: Belgium - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-40: Belgium - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-41: Netherlands - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-42: Netherlands - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-43: Switzerland - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-44: Switzerland - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-45: Turkey - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-46: Turkey - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-47: China - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-48: China - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-49: Japan - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-50: Japan - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-51: India - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-52: India - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-53: Australia - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-54: Australia - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-55: South Korea - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-56: South Korea - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-57: Thailand - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-58: Thailand - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-59: Malaysia - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-60: Malaysia - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-61: Indonesia - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-62: Indonesia - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-63: Philippines - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-64: Philippines - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-65: Brazil - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-66: Brazil - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-67: Mexico - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-68: Mexico - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-69: Argentina - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-70: Argentina - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-71: Saudi Arabia - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-72: Saudi Arabia - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-73: United Arab Emirates (UAE) - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-74: United Arab Emirates (UAE) - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-75: South Africa - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-76: South Africa - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-77: Rest of the World - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2022
  • Figure-78: Rest of the World - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 - 2030
  • Figure-79: F. Hoffman-La Roche - Global Revenue (Billion US$), 2018 - 2022
  • Figure-80: F. Hoffman-La Roche - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-81: Eurofins Scientific - Global Revenue (Billion US$), 2018 - 2022
  • Figure-82: Eurofins Scientific - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-83: Illumina, Inc. - Global Revenue (Billion US$), 2018 - 2022
  • Figure-84: Illumina, Inc. - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-85: Natera Inc. - Global Revenue (Million US$), 2018 - 2022
  • Figure-86: Natera Inc. - Forecast for Global Revenue (Million US$), 2023 - 2030
  • Figure-87: Abbott Laboratories - Global Revenue (Billion US$), 2018 - 2022
  • Figure-88: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-89: Thermo Fisher Scientific - Global Revenue (Billion US$), 2018 - 2022
  • Figure-90: Thermo Fisher Scientific - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-91: Quest Diagnostics - Global Revenue (Billion US$), 2018 - 2022
  • Figure-92: Quest Diagnostics - Forecast for Global Revenue (Billion US$), 2023 - 2030
  • Figure-93: Agilent Technologies - Global Revenue (Billion US$), 2018 - 2022
  • Figure-94: Agilent Technologies - Forecast for Global Revenue (Billion US$), 2023 - 2030

List of Tables

  • Table-01: Global - Cardiac Bio Implant Devices Market Share by Type (Percent), 2018 - 2022
  • Table-02: Global - Forecast for Cardiac Bio Implant Devices Market Share by Type (Percent), 2023 - 2030
  • Table-03: Global - Cardiac Bio Implant Devices Market Share by Application (Percent), 2018 - 2022
  • Table-04: Global - Forecast for Cardiac Bio Implant Devices Market Share by Application (Percent), 2023 - 2030
  • Table-05: Global - Cardiac Bio Implant Devices Market Share by End-User (Percent), 2018 - 2022
  • Table-06: Global - Forecast for Cardiac Bio Implant Devices Market Share by End-User (Percent), 2023 - 2030
  • Table-07: Global - Cardiac Bio Implant Devices Market Share by Countries (Percent), 2018 - 2022
  • Table-08: Global - Forecast for Cardiac Bio Implant Devices Market Share by Countries (Percent), 2023 - 2030
目次

Global Cardiac Bio-Implants Device Market size is estimated to be US$ 60.20 Billion by 2030, according to Renub Research. The most common cause of mortality worldwide is cardiovascular disease (CVD), which is characterized by constricted blood vessels that raise the risk of heart attacks and strokes. Blood flow restoration frequently involves surgical procedures, including coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI).

However, sufferers are nonetheless at danger for consequences which includes graft failure and in-stent restenosis (ISR) that may worsen their condition and boom mortality. Researchers are developing sophisticated cardiovascular bioimplants with sensors and actual-time tracking talents to address these issues. In order to prevent ISR and graft failure, those technologies are trying to find to discover ailment symptoms early, even before signs seem.

Worldwide cardiac bio-implants Market is predicted to show off a CAGR of 7.13% at some point of the period 2022-2030

A large driving force of market expansion is the growing attractiveness of bio-implant treatments that are desired over alternatives like arthroscopy and physical therapy due to their better fulfillment prices and biocompatibility. The market will grow as a result of things consisting of the improved prevalence of orthopedic and cardiovascular illnesses, the old aged populace, converting existence, and the growing use of beauty surgical operation.

According to data from the Centers for Disease Control and Prevention, coronary heart disorder, this influences over 20.1 million people elderly 20 and over, is the most commonplace form of coronary heart disease in the USA. An anticipated 805,000 heart attacks arise annually in the US, with one happening each 40 seconds. The growing incidence of chronic situations further will increase the demand for bioimplants. The global cardiac bio-implants market changed into worth USD 34.70 Billion in 2022.

Rising target sickness occurrence, heart assault incidence, remedy investment, and healthcare spending are driving the cardiac resynchronization remedy marketplace growth

The Cardiac Bio-Implant Device market is categorized into pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT). There are several motives why the CRT market is expanding. These consist of the high incidence of coronary coronary heart sickness, the upward push in heart failure and other cardiac problems, in addition to the growing range of aged people for the duration of the arena. The worldwide attractiveness of CRT is being driven by way of unhealthy existence and cardiovascular danger factors include diabetes, obesity, bad diets, state of no activity, and excessive alcohol use. These elements also make contributions to the improved incidence of heart disease. By 2050, a considerable part of the populace in the Asia-Pacific area is anticipated to be elderly, increasing the occurrence of cardiovascular sickness and the need for CRT.

Increasing product releases are anticipated to drive market expansion throughout the projected period. For instance, in February 2021, Medtronic unveiled the TYRX absorbable Antibacterial envelope. This unique, single-use envelope has antibacterial qualities and is made to support cardiac implantable electronic devices or implanted neurostimulators.

Rising number of people with cardiovascular disorders is predicted to propel the market for cardiac arrhythmias to considerable growth over the coming years, opening up attractive business prospects

By Application, The Cardiac Bio-Implant Device market is segmented into Arrhythmias, Myocardial Ischemia, Acute Myocardial infarction, and Heart Failure. A number of variables, such as the rising global incidence of unhealthy lifestyle choices like smoking, binge drinking, and obesity, which increase a person's susceptibility to cardiac arrhythmias, are fueling the expansion of the arrhythmias sector. Additionally, increasing patient awareness helps the market grow. When the heart beats too slowly, too fast, or irregularly, arrhythmias happen.

According to projections, 12.1 million Americans will have AFib by 2030. In 2019, 183,321 death certificates listed AFib as a contributing factor in 26,535 fatalities. Since AFib is associated with aging and women have greater life expectancies than men, it affects more women than men in Europe compared to African Americans. An important factor propelling the sector is the elevated death rate linked to arrhythmias. The industry is predicted to expand significantly over the next several years because of the rising number of individuals with cardiovascular disorders.

With the growing inclination for less invasive treatments in the Cardiac Catheterization laboratory sector, fluoroscopy-guided catheter-based cardiology operations have increased dramatically over the past several decades

By End User, The cardiac bio-implant device market is divided into Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization laboratories, and others. The growth of the Cardiac Catheterization laboratory market is primarily fueled by the increasing prevalence of cardiovascular disorders and advancements in Cardiac Catheterization lab technology. The rising incidence of cardiac diseases is expected to drive demand for Cardiac Catheterization lab services, which utilize various imaging techniques like angiography, echocardiography, and cardiac catheterization for diagnosis. For example, according to statistics from the British Heart Foundation, approximately 1,139,140 individuals were projected to be affected by heart and circulatory diseases in the UK in 2022, with 650,681 males and 488,320 females among them.

Globally, the American Heart Association estimates that during 2020, 244.1 Million humans may be living with ischemic coronary heart disorder (IHD), with a higher occurrence among men (141.0 million) in comparison to women (103.1 million). The market is driven by means of factors consisting of good sized improvements in catheterization system, accelerated operator understanding, the emergence of progressive strategies, and the growing incidence of cardiac complications, necessitating the establishment of cardiac catheterization labs globally.

Cardiac bio-implants market in the United States holds an enormous proportion and is projected to hold a regular growth trend at some stage in the upcoming years.

By Countries, The cardiac bio-implant devices market is broken up into the US, Canada, France, Germany, Italy, Spain, the UK, Belgium, the Netherlands, Switzerland, China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, the Philippines, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Turkey, the U.A.E., and Rest of World. The bio-implants market in the United States is driven by elements like the increasing prevalence of chronic illnesses and robust healthcare infrastructure, leading to huge growth. National health spending is projected to develop at a 5.4% annual rate, accomplishing USD 6.2 trillion by 2028. This rising healthcare expenditure creates possibilities for bio-implant improvement, whilst new product introductions like the T3 pro-tampered implant and Encode emergence healing Abutment through ZimVie further make contributions to market increase.

Key Company

F. Hoffman-La Roche, Eurofins Scientific, Illumina, Inc., Natera Inc., Abbott Laboratories, Thermo Fisher Scientific, Quest Diagnostics, and Agilent Technologies are the few companies working in the cardiac bio-implant device market.

Renub Research latest report "Cardiac Bio Implant Devices Market, Global Forecast By Type (Pacemaker, ICDs, Cardiac Resyncronization Therapy(CRT)), Application (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Heart Failure), End-User (Hospitals, Ambulatory Surgical Centers', Cardiac Catheterization Laboratories, Others), Country ( United States, Canada, France, Germany, Italy, Spain, the United Kingdom, Belgium, Netherlands, Switzerland, China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, Philippines, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Turkey, U.A.E., and ROW), Companies (F. Hoffman-La Roche, Eurofins Scientific, Illumina, Inc., Natera Inc., Abbott Laboratories, Thermo Fisher Scientific, Quest Diagnostics, and Agilent Technologies)" provides a detailed analysis of Cardiac Bio Implant Devices Industry.

Type - Market have been covered from 3 viewpoints:

  • 1. Pacemaker
  • 2. ICDs (Implantable Cardioverter Defibrillator)
  • 3. CRT (Cardiac Resynchronization Therapy)

Application - Market have been covered from 4 viewpoints:

  • 1. Arrhythmias
  • 2. Myocardial Ischemia
  • 3. Acute Myocardial Infarction
  • 4. Heart Failure

End-User - Market have been covered from 4 viewpoints:

  • 1. Hospitals
  • 2. Cardiac Care Centers
  • 3. Ambulatory Centers & Home Care
  • 4. Academic Institutes
  • 5. Others

Country - Market have been covered from 27 viewpoints:

  • 1. North America
    • 1.1. United States
    • 1.2. Canada
  • 2. Europe
    • 2.1. France
    • 2.2. Germany
    • 2.3. Italy
    • 2.4. Spain
    • 2.5. United Kingdom
    • 2.6. Belgium
    • 2.7. Netherlands
    • 2.8. Switzerland
    • 2.9. Turkey
  • 3. Asia Pacific
    • 3.1. China
    • 3.2. Japan
    • 3.3. India
    • 3.4. Australia
    • 3.5. South Korea
    • 3.6. Thailand
    • 3.7. Malaysia
    • 3.8. Indonesia
    • 3.9. Philippines
  • 4. Latin America
    • 4.1. Brazil
    • 4.2. Mexico
    • 4.3. Argentina
  • 5. Middle East & Africa
    • 5.1. Saudi Arabia
    • 5.2. U.A.E
    • 5.3. South Africa
  • 6. Rest of World

Company Insights:

  • Overview
  • Recent Development
  • Revenue

Companies Covered:

  • 1. F. Hoffman-La Roche
  • 2. Eurofins Scientific
  • 3. Illumina, Inc.
  • 4. Natera Inc.
  • 5. Abbott Laboratories
  • 6. Thermo Fisher Scientific
  • 7. Quest Diagnostics
  • 8. Agilent Technologies

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Cardiac Bio Implant Devices Market

6. Market Share - Cardiac Bio Implant Devices Market

  • 6.1 By Type
  • 6.2 By Application
  • 6.3 By End User
  • 6.4 By Countries

7. Type - Cardiac Bio Implant Devices Market

  • 7.1 Pacemaker
  • 7.2 ICDs (Implantable Cardioverter Defibrillator)
  • 7.3 CRT (Cardiac Resynchronization Therapy)

8. Application - Cardiac Bio Implant Devices Market

  • 8.1 Arrhythmias
  • 8.2 Myocardial Ischemia
  • 8.3 Acute Myocardial Infarction
  • 8.4 Heart Failure

9. End-User - Cardiac Bio Implant Devices Market

  • 9.1 Hospitals
  • 9.2 Ambulatory Surgical Centers
  • 9.3 Cardiac Catheterization Laboratories
  • 9.4 Others

10. Countries - Cardiac Bio Implant Devices Market

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 France
    • 10.2.2 Germany
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Belgium
    • 10.2.7 Netherlands
    • 10.2.8 Switzerland
    • 10.2.9 Turkey
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 Australia
    • 10.3.5 South Korea
    • 10.3.6 Thailand
    • 10.3.7 Malaysia
    • 10.3.8 Indonesia
    • 10.3.9 Philippines
  • 10.4 Latin America
    • 10.4.1 Brazil
    • 10.4.2 Mexico
    • 10.4.3 Argentina
  • 10.5 Middle East & Africa
    • 10.5.1 Saudi Arabia
    • 10.5.2 U.A.E
    • 10.5.3 South Africa
  • 10.6 Rest of World

11. Porter Five Forces Analysis - Cardiac Bio Implant Devices Market

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Rivalry
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis - Cardiac Bio Implant Devices Market

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threat

13. Key Players Analysis

  • 13.1 F. Hoffman-La Roche
    • 13.1.1 Overview
    • 13.1.2 Recent Development
    • 13.1.3 SWOT Analysis
    • 13.1.4 Revenue
  • 13.2 Eurofins Scientific
    • 13.2.1 Overview
    • 13.2.2 Recent Development
    • 13.2.3 SWOT Analysis
    • 13.2.4 Revenue
  • 13.3 Illumina, Inc.
    • 13.3.1 Overview
    • 13.3.2 Recent Development
    • 13.3.3 SWOT Analysis
    • 13.3.4 Revenue
  • 13.4 Natera Inc.
    • 13.4.1 Overview
    • 13.4.2 Recent Development
    • 13.4.3 SWOT Analysis
    • 13.4.4 Revenue
  • 13.5 Abbott Laboratories
    • 13.5.1 Overview
    • 13.5.2 Recent Development
    • 13.5.3 SWOT Analysis
    • 13.5.4 Revenue
  • 13.6 Thermo Fisher Scientific
    • 13.6.1 Overview
    • 13.6.2 Recent Development
    • 13.6.3 SWOT Analysis
    • 13.6.4 Revenue
  • 13.7 Quest Diagnostics
    • 13.7.1 Overview
    • 13.7.2 Recent Development
    • 13.7.3 SWOT Analysis
    • 13.7.4 Revenue
  • 13.8 Agilent Technologies
    • 13.8.1 Overview
    • 13.8.2 Recent Development
    • 13.8.3 SWOT Analysis
    • 13.8.4 Revenue